Smoking Cessation After Hospitalization for a Cardiopulmonary Illness

Smoking Cessation Clinical Trial

— STOPP  

Official title:

Smoking Cessation Treatment of CardioPulmonary Hospitalized Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01791803
• Other study ID #: STOPP
• Status: Completed
• Phase: N/A
• First received: February 12, 2013
• Last updated: May 17, 2017
• Start date: January 2006
• Est. completion date: May 2009

Study information

• Verified date: May 2017
• Source: North Shore Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Smoking-related cardiopulmonary diseases account for a large number of hospital admissions. We investigated the efficacy of hypnotherapy as an aid to a counseling-based smoking cessation program in improving quit rates of hospitalized smoking patients at 12 and 26 weeks after hospital discharge. We compared outcomes with hospitalized patients who received more conventional therapy, namely nicotine replacement therapy, or patients who decided to quit on their own. We also compared smoking cessation rates at 12 and 26 weeks after hospitalization among patients admitted with a cardiac or a pulmonary diagnosis.

Description:

Hospitalized patients with a cardiopulmonary diagnosis who were contemplating quitting were recruited into 4 groups: Hypnotherapy, Nicotine replacement therapy (NRT), both hypnotherapy and NRT, and self-quit group. All patients received self-help brochures and in-hospital counseling. Intervention groups received more extensive counseling, free NRT supply for a month and/or a 90 minute hypnotherapy session within 2 weeks of discharge. They also had follow up telephone counseling at 1,2,4,8 and 12 weeks after discharge. 7 day prevalence of tobacco abstinence rates at 26 weeks after hospitalization were verified by self report and urinary Cotinine levels.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 164
• Est. completion date: May 2009
• Est. primary completion date: May 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Hospitalized patients with a Cardiopulmonary admission.

Exclusion Criteria:

• Terminal illness, history of Serious Psychiatric illness or substance abuse, Pregnancy, Cognitive or language barriers.

Related Conditions & MeSH terms

• Smoking Cessation

Intervention

Behavioral:
• hypnotherapy
One 90 minute session within 2 weeks of hospital discharge

Drug:
• Nicotine
free one month supply after hospital discharge

Locations

Country	Name	City	State
United States	North Shore Medical Center	Salem	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
North Shore Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Abstinence From Smoking	Assessed by 7-day prevalence of verified tobacco abstinence at 26 weeks after hospitalization for a cardiopulmoanry illness. Verification was confirmed biochemically by urine Cotinine testing or by telephone and discussion with a household proxy. Patients lost to follow up were considered to be persistent smokers.	at 26 weeks after hospitalization
Secondary	Smoking Cessation	Abstinence from smoking at 12 weeks after hospitalization was measured by self reported 7-day prevalence and verified urinary Cotinine test. This included participants in groups receiving hypnotherapy, NRT or both. Self quit group was not approached until 26 weeks after discharge. Patients lost to follow up were considered smokers.	at 12 weeks after hospitalization
Secondary	Smoking Abstinence Rate at 12 and 26 Weeks	Abstinence rates were calculated for patients hospitalized with a cardiac or a pulmonary diagnosis.	12 weeks and 26 weeks after hospital discharge